Hippocampal Neurometabolite Changes in Hypothyroidism: An In Vivo1H Magnetic Resonance Spectroscopy Study Before and After Thyroxine Treatment. (15th September 2016)

• Record Type: Journal Article
• Authors: Singh, S.; Rana, P.; Kumar, P.; Shankar, L. R.; Khushu, S.
• Is Part Of: Journal of neuroendocrinology. Volume 28:Number 9(2016:Sep.)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2016-09-15
• Subjects: proton magnetic resonance spectroscopy -- hypothyroidism -- hippocampus; Neuroendocrinology -- Periodicals; 616.4
• DOI: 10.1111/jne.12399
• Languages: English
• ISSNs: 0953-8194

Abstract

Abstract : The hippocampus is a thyroid hormone receptor‐rich region of the brain. A change in thyroid hormone levels may be responsible for an alteration in hippocampal‐associated function, such as learning, memory and attention. Neuroimaging studies have shown functional and structural changes in the hippocampus as a result of hypothyroidism. However, the underlying process responsible for this dysfunction remains unclear. Therefore, the present study aimed to investigate the metabolic changes in the brain of adult hypothyroid patients during pre‐ and post‐thyroxine treatment using in vivo proton magnetic resonance spectroscopy ( 1 H MRS). 1 H MRS was performed in both healthy control subjects (n = 15) and hypothyroid patients (n = 15) (before and after thyroxine treatment). The relative ratios of the neurometabolites were calculated using the linear combination model (LCModel). Our results revealed a significant decrease of glutamate (Glu) (P = 0.045) and myo‐inositol (mI) (P = 0.002) levels in the hippocampus of hypothyroid patients compared to controls. No significant changes in metabolite ratios were observed in the hypothyroid patients after thyroxine treatment. The findings of the present study reveal decreased Glu/tCr and mI/tCr ratios in the hippocampus of hypothyroid patients and these metabolite alterations persisted even after the patients became clinically euthyroid subsequent to thyroxine treatment.